USPTO serial 79447332
CHROMATINLENS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- LUEKEN, ABIGAIL JOSEPHINE
- Law office
- TMEG LAW OFFICE 109
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with CHROMATINLENS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Synthetic promoters for scientific and industrial purposes; gene expression vectors for scientific and industrial purposes; synthetic enhancers in gene expression cassettes for scientific and industrial purposes; chemical and enzyme preparations for scientific and industrial purposes; regulatory proteins for scientific and industrial use; diagnostic biomarker reagents for scientific and industrial purposes; chemical reagents for use in genetic research; assays and reagents for use in genetic research; nucleic acid sequences and chemical reagents for scientific and industrial purposes; synthetic promoters for crops; growth promoters for use in industry; genetic switches and promoters for scientific and industrial purposes; DNA sequences and RNA sequences for scientific and industrial purposes; genetic carriers, namely cells and viruses for scientific and industrial purposes; transgenes for scientific and industrial purposes; genetic reagents for scientific and industrial purposes; target antigens for scientific and industrial purposes. | ACTIVE | — |
| 005 | Synthetic promoters for medical and clinical purposes; gene expression vectors for medical and clinical purposes; synthetic enhancers in gene expression cassettes for medical or clinical use; regulatory proteins for medical use; genetic switches and promoters for medical and clinical purposes; DNA sequences and RNA sequences for medical purposes; genetic carriers, namely cells and viruses for medical and clinical purposes; chemical and enzyme preparations for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; nucleic acid sequences and chemical reagents for medical and veterinary purposes; RNA therapeutics; pharmaceutical preparations for use in targeted pharmaceutical therapies; transgenes for medical purposes; gene therapy pharmaceuticals; biotechnological preparations for medical use; biological compounds for use in the targeted pharmaceutical therapies; genetic reagents for medical and clinical purposes; biological preparations for use in cells and cell cultures for medical and clinical use; target antigens for medical use. | ACTIVE | — |
| 009 | Databases; data sets, recorded or downloadable; epigenetic data-sets; downloadable data sets in the fields of multiomics, gene expression and biopharmaceuticals; data processing systems; downloadable computer software in the fields of epigenetics, gene expression, gene regulation, genomics, genetic markers, functional genomics, biomarkers, bioinformatics, bio-processing, biologics, genomic signals, gene therapies, genetic sequencing, promoters, synthetic promoters, gene expression cassettes, vectors, recombinant protein production, cell engineering, biopharmaceuticals, molecular genetics, DNA assembly, DNA synthesis, DNA sequencing, RNA sequencing, transgenes, predicting protein expression, synthetic biology, engineering biology, protein engineering, cells, biochemical reagents, recombinant protein production, viral vector engineering, modulating therapeutics, and predicting protein expression; downloadable computer software for the structural and functional analysis of genomes; downloadable computer software for scientific analysis of genetic sequences; downloadable computer software in the nature of algorithms used for medical research and scientific discovery; algorithms, being computer software; bioinformatics software; data processing software; data mining software; artificial intelligence and machine learning software; computer software platforms; devices for analysing genome information; nucleic acid sequencers for scientific purposes; signal processing apparatus. | ACTIVE | — |
| 042 | Design and development of novel synthetic promoters in the field of genetics; design, development and analysis of epigenetic data systems; genetic engineering services; genetic sequencing and genotyping services; genetic sequence optimisation services; DNA and RNA sequencing services; Polymerase Chain Reaction [PCR] services; gene regulation control services; genome amplification; gene silencing services; structural and functional analysis of genomes; analysis and profiling of gene expression; gene regulatory network analysis; genetic mapping and testing for scientific purposes; genetic engineering services relating to plants; cell engineering services, namely cell suppression, cell activation, and cell programming and reprogramming; culturing of cells for scientific or medical research purposes; synthetic biology services; metabolic engineering services; scientific research services in the field of biologics production; biological laboratory services; research, development and analysis services in the fields of epigenetics, gene expression, gene regulation, genomics, genetic markers, functional genomics, biomarkers, bioinformatics, bio-processing, biologics, genomic signals, gene therapies, genetic sequencing, promoters, synthetic promoters, gene expression cassettes, vectors, recombinant protein production, cell engineering, biopharmaceuticals, molecular genetics, DNA assembly, DNA synthesis, DNA sequencing, RNA sequencing, transgenes, predicting protein expression, synthetic biology, engineering biology, protein engineering, cells, biochemical reagents, recombinant protein production, viral vector engineering, modulating therapeutics, and predicting protein expression; research, development and analysis services in the field of genetic dark matter; research, development and analysis services in the field of gene expression systems; contract research services relating to promoters and gene expression vectors; computer aided analysis services in the field of epigenetics; design, development and maintenance of databases; hosting of online databases featuring scientific data in the field of multiomics; scientific research conducted using databases; data mining services; analysis of technical data; preparation of technical reports; design and development of lab information management systems; design of data processing systems; design and development of computer platforms; design, development and maintenance of software in the fields of epigenetics, gene expression, gene regulation, genomics, genetic markers, functional genomics, biomarkers, bioinformatics, bio-processing, biologics, genomic signals, gene therapies, genetic sequencing, promoters, synthetic promoters, gene expression cassettes, vectors, recombinant protein production, cell engineering, biopharmaceuticals, molecular genetics, DNA assembly, DNA synthesis, DNA sequencing, RNA sequencing, transgenes, predicting protein expression, synthetic biology, engineering biology, protein engineering, cells, biochemical reagents, recombinant protein production, viral vector engineering, modulating therapeutics, and predicting protein expression; providing online, non-downloadable software in the fields of epigenetics, gene expression, gene regulation, genomics, genetic markers, functional genomics, biomarkers, bioinformatics, bio-processing, biologics, genomic signals, gene therapies, genetic sequencing, promoters, synthetic promoters, gene expression cassettes, vectors, recombinant protein production, cell engineering, biopharmaceuticals, molecular genetics, DNA assembly, DNA synthesis, DNA sequencing, RNA sequencing, transgenes, predicting protein expression, synthetic biology, engineering biology, protein engineering, cells, biochemical reagents, recombinant protein production, viral vector engineering, modulating therapeutics, and predicting protein expression; design, development and maintenance of machine learning software for use in bioinformatics, genetic sequencing, predicting protein expression, cell suppression and analysis of cell behaviours; design, development and maintenance of software algorithms for in the fields of epigenetics, medical research and scientific discovery; development and testing of computing methods, algorithms and software; consultancy, information and advisory services relating to all of the aforesaid services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 25, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 25, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 14, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 13, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 3, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 3, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |